Differential Contractile Reactivity to Nucleotides in Femoral Arteries of OLETF and LETO Rats

  • Matsumoto Takayuki
    Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University
  • Takayanagi Keisuke
    Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University
  • Kojima Mihoka
    Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University
  • Taguchi Kumiko
    Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University
  • Kobayashi Tsuneo
    Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University

この論文をさがす

抄録

<p>Extracellular nucleotides play an important role in the regulation of vascular function, and an abnormal vascular function is an important participant in the development and progression of diabetic vascular complications. The purpose of this study was to determine whether contractile responses induced by extracellular nucleotides and a dinucleotide, uridine adenosine tetraphosphate (Up4A), in femoral arteries would be altered at the chronic stage of type 2 diabetes. We determined the changes in contractile reactivity induced by ATP, uridine triphosphate (UTP), uridine diphosphate (UDP), and Up4A in the femoral arteries of Otsuka Long–Evans Tokushima Fatty (OLETF) rats (aged male type 2 diabetic rats) and, Long–Evans Tokushima Otsuka (LETO) rats (controls for OLETF rats). ATP-induced contractions were greater in OLETF rats than in LETO rats. UTP-induced contractions were lower in OLETF rats than in LETO rats. UDP- and Up4A-induced contractions were similar between OLETF and LETO rats. The femoral artery contractile changes induced by the extracellular nucleotides and dinucleotide were similar when nitric oxide synthase was inhibited. These results suggest that the extent of femoral artery contractile reactivity to nucleotides/dinucleotides differs during long-term duration of type 2 diabetes.</p>

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (28)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ